Thomas Stiermaier, MD; Suzanne de Waha, MD;

Slides:



Advertisements
Similar presentations
prognosis of patients with Acute Myocardial Infarction remains dismal.
Advertisements

Radial versus Femoral Randomized Investigation in ST Elevation Acute Coronary Syndrome the RIFLE STEACS study Enrico Romagnoli, MD PhD Principal investigators:
TOTAL Culprit lesion thrombus burden after manual aspiration thrombectomy or PCI alone in STEMI The OCT Substudy of the TOTAL (ThrOmbecTomy versus PCI.
on behalf of the TOTAL Investigators
TOTAL Stroke in the TOTAL trial: Randomized trial of manual aspiration Thrombectomy in STEMI TOTAL Trial Investigators.
University Medical Center Groningen Thrombus aspiration during primary PCI FZ Thrombus Aspiration during Percutaneous coronary intervention in Acute.
Francesco Liistro Cardiovascular Department, Arezzo, Italy Impact of Thrombus Aspiration on Myocardial Tissue Reperfusion and Left Ventricular Functional.
UNIVERSITÄT LEIPZIG H E R Z Z E N T R U M Infarct transmurality and infarct size assessed by delayed enhancement magnetic resonance imaging: Association.
Cost-Effectiveness of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention in Patients with Stable Coronary Disease: Results from the FAME.
: PROFI : A Prospective, Randomized Trial of Proximal Balloon Occlusion vs. Filter Embolic Protection in Patients Undergoing Carotid Stenting Klaudija.
Trial Vignettes 1-3 Mark Mason Harefield Hospital Royal Brompton and Harefield NHS Trust.
CIT 2016 Template Title 40 pt Bold Arial David Liu, MD Subtitle 34 pt Arial Bold Italics.
Randomized Early versus Late AbciXimab in Acute Myocardial Infarction treated with primary coronary intervention (RELAx-AMI Trial) Mauro Maioli M.D., Francesco.
Ten Year Outcome of Coronary Artery Bypass Graft Surgery Versus Medical Therapy in Patients with Ischemic Cardiomyopathy Results of the Surgical Treatment.
Cardioprotective Effects of Postconditioning in Patients Treated with Primary PCI Evaluated with Magnetic Resonance Jacob T Lønborg Niels Vejlstrup, Erik.
Effect of Thrombus Aspiration in Patients With Myocardial Infarction Presenting Late After Symptom Onset Steffen Desch, MD Thomas Stiermaier, MD; Suzanne.
A Prospective, Randomized Trial of a Paclitaxel coated Balloon vs. uncoated Balloon Angioplasty in Patients with Drug- Eluting Stent Restenosis PEPCAD-DES.
Final 5 year results from the all-comer COMPARE trial: a prospective randomized comparison between Xience-V and Taxus Liberté TCT 2013 San Francisco Pieter.
Lessons from PARTNER I (A & B) CRT, Washington DC, Feb 5, 2012
Disclosure Statement of Financial Interest
De Novo and Restenotic Coronary Lesions
Is the Debate Over? Routine Thrombus Aspiration in STEMI (From TAPAS to INFUSE-AMI to TASTE to TOTAL) Stefan James Professor of Cardiology Uppsala Clinical.
David E. Kandzari, MD on behalf of the BIONICS investigators
Disclosure Statement of Financial Interest
Total Occlusion Study of Canada (TOSCA-2) Trial
Valvuloplasty Scoring Balloon for the Treatment of Critical Aortic Valve Stenosis - Design of a FIM Study - Gary Gershony, MD, FACC, FSCAI, FAHA, FRCPC.
Disclosure Statement of Financial Interest
Ajay J. Kirtane, MD I have no real or apparent conflicts of interest to report.
VELOCITY A Prospective, Randomized Trial of Peritoneal Hypothermia in Patients with Acute STEMI Undergoing PCI Gregg W. Stone, MD Columbia University Medical.
Debate: Prophylactic Support Increases Risk With Little Benefit
Updates From NOTION: The First All-Comer TAVR Trial
How to Build A Successful Clinical Research Program
Advanced CTO Techniques:
Non-Inferiority Exposed: Uses and Abuses
On behalf of the PRECOMBAT Investigators
Thrombus Management in the Cath Lab
Washington Hospital Center, Division of Cardiology
DKCRUSH V Shao-Liang Chen, MD DKCRUSH V
The DKCRUSH-V Randomized Trial
Comprehensive Meta-Analysis of DES vs
Crossing CTOs via Planned Dissection: LaST (Limited Antegrade Subintimal Tracking): from knuckle wire to Bridgepoint Craig A. Thompson, M.D., MMSc. Director,
A prospective, randomized trial of
EXCELLA Studies - Novolimus Elution from PLLA Polymer Coated Stents DESyne® and DESyne BD: Design Specifications and Clinical Updates Stefan Verheye,
Presenter Disclosure Information
Crossing CTOs via Planned Dissection: LaST (Limited Antegrade Subintimal Tracking): from knuckle wire to Bridgepoint Craig A. Thompson, M.D., MMSc. Director,
Is There a Role for Aspiration in STEMI?
Collagenase for CTO: An update Bradley H
Three Years Follow Up. SORT OUT II
CIT 2018 Template Title 40 pt Bold Arial
CIT 2018 Template Title 40 pt Bold Arial
European Society of Cardiology 2003
CIT 2017 Template Title 40 pt Bold Arial
The HORIZONS-AMI Trial
Comparison of Everolimus- and Biolimus-Eluting Coronary Stents With Everolimus-Eluting Bioresorbable Vascular Scaffolds: 2-year Outcomes of the EVERBIO.
A Systematic Review and Meta-analysis of Randomized Trials of Manual Thrombectomy in ST elevation myocardial infarction Investigators: Ashraf Alazzoni,
Five-Year Cumulative Rates of Clinical Events after Cypher™ Stent Implantation: Insights from a Patient-Level Pooled Analysis of Four Randomized Trials.
Impact of clopidogrel loading dose on the safety and effectiveness of bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction:
CIT 2018 Template Title 40 pt Bold Arial
CIT 2017 Template Title 40 pt Bold Arial
CIT 2017 Template Title 40 pt Bold Arial
Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents: 70 restenotic cases from a cohort of.
Division of Endovascular Interventions
Comprehensive Meta-Analysis of DES vs
CIT 2017 Template Title 40 pt Bold Arial
Gregg W. Stone, MD Columbia University Medical Center
Federico M. Asch, MD Director, Echocardiographic Core Lab
Maintenance of Long-Term Clinical Benefit with
Infarct Size after Primary Angioplasty Patients With Bivalirudin
Title 40pt Trebuchet MS Bold
CIT 2018 Template Title 40 pt Bold Arial
Presentation transcript:

Thomas Stiermaier, MD; Suzanne de Waha, MD; Effect of Thrombus Aspiration in Patients With Myocardial Infarction Presenting Late After Symptom Onset Steffen Desch, MD Thomas Stiermaier, MD; Suzanne de Waha, MD; Philipp Lurz, MD, PhD; Matthias Gutberlet, MD; Marcus Sandri, MD; Norman Mangner, MD; Enno Boudriot, MD; Michael Woinke, MD; Sandra Erbs, MD; Gerhard Schuler, MD; Georg Fuernau, MD; Ingo Eitel, MD; Holger Thiele, MD

Disclosure Statement of Financial Interest Within the past 12 months, I or my spouse/partner have had a financial interest/arrangement or affiliation with the organization(s) listed below. Affiliation/Financial Relationship Company Grant/Research Support Consulting Fees/Honoraria Major Stock Shareholder/Equity Royalty Income Ownership/Founder Intellectual Property Rights Other Financial Benefit Medtronic None related to the study

Background Recent trials on thrombus aspiration in STEMI reported disappointing results with no reduction in mortality and possibly an increase in stroke. ↓ Symptom onset: 12 h 24 h 36 h 48 h This is the Bulleted List slide. To create this particular slide, click the NEW SLIDE button on your toolbar and choose the BULLETED LIST format. (Top row, second from left) The Sub-Heading and footnote will not appear when you insert a new slide. If you need either one, copy and paste it from the sample slide. If you choose not to use a Sub-Heading, let us know when you hand in your presentation for clean-up and we’ll adjust where the bullets begin on your master page. Also, be sure to insert the presentation title onto the BULLETED LIST MASTER as follows: Choose View / Master / Slide Master from your menu. Select the text at the bottom of the slide and type in a short version of your presentation title. Click the SLIDE VIEW button in the lower left hand part of your screen to return to the slide show. (Small white rectangle) TASTE TOTAL ? Frobert et al. N Engl J Med 2013;369:1587-97. Jolly et al. N Engl J Med 2015;372:1389-98. 2

Background Hypothesis Design Routine thrombus aspiration reduces microvascular obstruction (MVO) assessed by cardiac magnetic resonance imaging (CMR) in patients with subacute STEMI presenting between 12 and 48 hours after symptom onset. Design This is the Bulleted List slide. To create this particular slide, click the NEW SLIDE button on your toolbar and choose the BULLETED LIST format. (Top row, second from left) The Sub-Heading and footnote will not appear when you insert a new slide. If you need either one, copy and paste it from the sample slide. If you choose not to use a Sub-Heading, let us know when you hand in your presentation for clean-up and we’ll adjust where the bullets begin on your master page. Also, be sure to insert the presentation title onto the BULLETED LIST MASTER as follows: Choose View / Master / Slide Master from your menu. Select the text at the bottom of the slide and type in a short version of your presentation title. Click the SLIDE VIEW button in the lower left hand part of your screen to return to the slide show. (Small white rectangle) Prospective, randomized, controlled, single-blind Single-center 3

Main Inclusion Criteria Main Exclusion Criteria Methods Main Inclusion Criteria STEMI ≥12 and ≤48 hours after symptom onset Age ≥18 and ≤90 years Main Exclusion Criteria Prior thrombolysis Contraindications for CMR Life expectancy <6 months This is the Bulleted List slide. To create this particular slide, click the NEW SLIDE button on your toolbar and choose the BULLETED LIST format. (Top row, second from left) The Sub-Heading and footnote will not appear when you insert a new slide. If you need either one, copy and paste it from the sample slide. If you choose not to use a Sub-Heading, let us know when you hand in your presentation for clean-up and we’ll adjust where the bullets begin on your master page. Also, be sure to insert the presentation title onto the BULLETED LIST MASTER as follows: Choose View / Master / Slide Master from your menu. Select the text at the bottom of the slide and type in a short version of your presentation title. Click the SLIDE VIEW button in the lower left hand part of your screen to return to the slide show. (Small white rectangle) 4

Methods Primary Endpoint Extent of MVO on late gadolinium enhancement CMR at day 1 - 4 This is the Bulleted List slide. To create this particular slide, click the NEW SLIDE button on your toolbar and choose the BULLETED LIST format. (Top row, second from left) The Sub-Heading and footnote will not appear when you insert a new slide. If you need either one, copy and paste it from the sample slide. If you choose not to use a Sub-Heading, let us know when you hand in your presentation for clean-up and we’ll adjust where the bullets begin on your master page. Also, be sure to insert the presentation title onto the BULLETED LIST MASTER as follows: Choose View / Master / Slide Master from your menu. Select the text at the bottom of the slide and type in a short version of your presentation title. Click the SLIDE VIEW button in the lower left hand part of your screen to return to the slide show. (Small white rectangle) 5

Methods Secondary Endpoints CMR - Infarct size - Myocardial salvage - LV volumes and ejection fraction Angiography - TIMI flow post-PCI - Myocardial blush grade post-PCI Enzymatic infarct size - High-sensitivity troponin T after 24 and 48 hours Clinical outcome - 30-day follow-up - All-cause and cardiovascular death, myocardial reinfarction, TLR, TVR, stent thrombosis, stroke This is the Bulleted List slide. To create this particular slide, click the NEW SLIDE button on your toolbar and choose the BULLETED LIST format. (Top row, second from left) The Sub-Heading and footnote will not appear when you insert a new slide. If you need either one, copy and paste it from the sample slide. If you choose not to use a Sub-Heading, let us know when you hand in your presentation for clean-up and we’ll adjust where the bullets begin on your master page. Also, be sure to insert the presentation title onto the BULLETED LIST MASTER as follows: Choose View / Master / Slide Master from your menu. Select the text at the bottom of the slide and type in a short version of your presentation title. Click the SLIDE VIEW button in the lower left hand part of your screen to return to the slide show. (Small white rectangle) 6

Percutaneous Coronary Intervention Methods Percutaneous Coronary Intervention Thrombus aspiration: - Before first balloon inflation - Manual aspiration catheter (Export® AP, 6 French, Medtronic Inc.) - Minimum of 2 passages recommended Additional procedural strategies: - According to current best practice (e.g. heparin/bivalirudin ± GP IIb/IIIa-inhibitor) This is the Bulleted List slide. To create this particular slide, click the NEW SLIDE button on your toolbar and choose the BULLETED LIST format. (Top row, second from left) The Sub-Heading and footnote will not appear when you insert a new slide. If you need either one, copy and paste it from the sample slide. If you choose not to use a Sub-Heading, let us know when you hand in your presentation for clean-up and we’ll adjust where the bullets begin on your master page. Also, be sure to insert the presentation title onto the BULLETED LIST MASTER as follows: Choose View / Master / Slide Master from your menu. Select the text at the bottom of the slide and type in a short version of your presentation title. Click the SLIDE VIEW button in the lower left hand part of your screen to return to the slide show. (Small white rectangle) 7

Cardiac Magnetic Resonance Imaging Methods Cardiac Magnetic Resonance Imaging Standard protocol / day 1 - 4 CMR core laboratory - University Heart Center Lübeck, Germany - Assessment by fully blinded operators Standard protocol /IIIa inhibitors ) Function 2Ch/4Ch T2 SA Function SA LGE 2Ch/4Ch/SA Area at risk LV-EF, LVEDV, LVESV MVO, infarct size This is the Bulleted List slide. To create this particular slide, click the NEW SLIDE button on your toolbar and choose the BULLETED LIST format. (Top row, second from left) The Sub-Heading and footnote will not appear when you insert a new slide. If you need either one, copy and paste it from the sample slide. If you choose not to use a Sub-Heading, let us know when you hand in your presentation for clean-up and we’ll adjust where the bullets begin on your master page. Also, be sure to insert the presentation title onto the BULLETED LIST MASTER as follows: Choose View / Master / Slide Master from your menu. Select the text at the bottom of the slide and type in a short version of your presentation title. Click the SLIDE VIEW button in the lower left hand part of your screen to return to the slide show. (Small white rectangle) 8

Sample Size Calculation Methods Sample Size Calculation Mean difference 2.0 %LV Standard deviation 3.5 %LV Power 90% Alpha 0.05 Drop-out 15% Sample size, n: 152 2 x 76 This is the Bulleted List slide. To create this particular slide, click the NEW SLIDE button on your toolbar and choose the BULLETED LIST format. (Top row, second from left) The Sub-Heading and footnote will not appear when you insert a new slide. If you need either one, copy and paste it from the sample slide. If you choose not to use a Sub-Heading, let us know when you hand in your presentation for clean-up and we’ll adjust where the bullets begin on your master page. Also, be sure to insert the presentation title onto the BULLETED LIST MASTER as follows: Choose View / Master / Slide Master from your menu. Select the text at the bottom of the slide and type in a short version of your presentation title. Click the SLIDE VIEW button in the lower left hand part of your screen to return to the slide show. (Small white rectangle) 9

Study Flow 152 patients with subacute STEMI 12 and 48 hours after symptom onset Thrombus aspiration (n=70) Standard PCI Only (n=74) No CMR (n=14) No CMR (n=19) Final diagnosis other than STEMI (n=8) 1:1 randomization Received allocated treatment (n=70) Received allocated treatment (n=69) Intention-to-treat (n=56) Intention-to-treat (n=55) Primary endpoint: Microvascular obstruction This is the Bulleted List slide. To create this particular slide, click the NEW SLIDE button on your toolbar and choose the BULLETED LIST format. (Top row, second from left) The Sub-Heading and footnote will not appear when you insert a new slide. If you need either one, copy and paste it from the sample slide. If you choose not to use a Sub-Heading, let us know when you hand in your presentation for clean-up and we’ll adjust where the bullets begin on your master page. Also, be sure to insert the presentation title onto the BULLETED LIST MASTER as follows: Choose View / Master / Slide Master from your menu. Select the text at the bottom of the slide and type in a short version of your presentation title. Click the SLIDE VIEW button in the lower left hand part of your screen to return to the slide show. (Small white rectangle) 10

Baseline Characteristics Results Baseline Characteristics Thrombus aspiration n = 70 Standard PCI n = 74 Age, years 66 ±12 66 ± 15 Hypertension, n (%) 55/70 (79) 48/74 (65) Hyperlipoproteinemia, n (%) 11/70 (16) 17/74 (23) Diabetes mellitus, n (%) 22/70 (31) 25/74 (34) Ongoing signs of ischemia, n (%) 28/57 (49) 34/62 (55) Symptom-onset-to-balloon, hours 26 ± 13 29 ± 12 TIMI flow pre-PCI 0, n (%) 44/70 (63) 46/74 (62) GP IIb/IIIa-inhibitor, n (%) 18/70 (25) 21/74 (28) This is the Bulleted List slide. To create this particular slide, click the NEW SLIDE button on your toolbar and choose the BULLETED LIST format. (Top row, second from left) The Sub-Heading and footnote will not appear when you insert a new slide. If you need either one, copy and paste it from the sample slide. If you choose not to use a Sub-Heading, let us know when you hand in your presentation for clean-up and we’ll adjust where the bullets begin on your master page. Also, be sure to insert the presentation title onto the BULLETED LIST MASTER as follows: Choose View / Master / Slide Master from your menu. Select the text at the bottom of the slide and type in a short version of your presentation title. Click the SLIDE VIEW button in the lower left hand part of your screen to return to the slide show. (Small white rectangle) 11

Primary Endpoint: Microvascular Obstruction Results Primary Endpoint: Microvascular Obstruction Thrombus aspiration Microvascular obstruction, %LV Standard PCI only p=0.47 5 4 3 1 2 3.1 ± 4.4 2.5 ± 4.0 This is the Bulleted List slide. To create this particular slide, click the NEW SLIDE button on your toolbar and choose the BULLETED LIST format. (Top row, second from left) The Sub-Heading and footnote will not appear when you insert a new slide. If you need either one, copy and paste it from the sample slide. If you choose not to use a Sub-Heading, let us know when you hand in your presentation for clean-up and we’ll adjust where the bullets begin on your master page. Also, be sure to insert the presentation title onto the BULLETED LIST MASTER as follows: Choose View / Master / Slide Master from your menu. Select the text at the bottom of the slide and type in a short version of your presentation title. Click the SLIDE VIEW button in the lower left hand part of your screen to return to the slide show. (Small white rectangle) 12

MVO in Predefined Subgroups Results MVO in Predefined Subgroups 0 1 2 All Patients Male sex Female sex Diabetes No diabetes TIMI thrombus grade 0-4 TIMI thrombus grade 5 TIMI-flow pre PCI 0-1 TIMI-flow pre PCI 2-3 GP IIb/IIIa-inhibitor No GP IIb/IIIa-inhibitor 111 86/111 25/111 32/111 79/111 38/111 73/111 77/111 34/111 Thrombectomy better Standard PCI Baseline variable No. of patients Mean Difference in MVO %LV (95% CI) 0.95 0.29 0.82 0.53 0.35 P-value for interaction This is the Bulleted List slide. To create this particular slide, click the NEW SLIDE button on your toolbar and choose the BULLETED LIST format. (Top row, second from left) The Sub-Heading and footnote will not appear when you insert a new slide. If you need either one, copy and paste it from the sample slide. If you choose not to use a Sub-Heading, let us know when you hand in your presentation for clean-up and we’ll adjust where the bullets begin on your master page. Also, be sure to insert the presentation title onto the BULLETED LIST MASTER as follows: Choose View / Master / Slide Master from your menu. Select the text at the bottom of the slide and type in a short version of your presentation title. Click the SLIDE VIEW button in the lower left hand part of your screen to return to the slide show. (Small white rectangle) 13

Secondary Endpoints: Infarct Size and Salvage Results Secondary Endpoints: Infarct Size and Salvage Thrombus aspiration Infarct size; %LV Standard PCI only p=0.49 40 30 20 10 Thrombus aspiration Myocardial salvage index Standard PCI only p=0.63 40 30 20 10 29±31 30±17 27±17 26±21 This is the Bulleted List slide. To create this particular slide, click the NEW SLIDE button on your toolbar and choose the BULLETED LIST format. (Top row, second from left) The Sub-Heading and footnote will not appear when you insert a new slide. If you need either one, copy and paste it from the sample slide. If you choose not to use a Sub-Heading, let us know when you hand in your presentation for clean-up and we’ll adjust where the bullets begin on your master page. Also, be sure to insert the presentation title onto the BULLETED LIST MASTER as follows: Choose View / Master / Slide Master from your menu. Select the text at the bottom of the slide and type in a short version of your presentation title. Click the SLIDE VIEW button in the lower left hand part of your screen to return to the slide show. (Small white rectangle) 14

Secondary Endpoints: LV Function and Volumes Results Secondary Endpoints: LV Function and Volumes LVEDV, ml p=0.77 50 Thrombus aspiration LV ejection fraction, % Standard PCI only p=0.44 40 20 10 45±12 46±11 30 200 160±52 157±12 150 100 50 89±34 88±38 120 LVESV, ml p=0.89 90 60 This is the Bulleted List slide. To create this particular slide, click the NEW SLIDE button on your toolbar and choose the BULLETED LIST format. (Top row, second from left) The Sub-Heading and footnote will not appear when you insert a new slide. If you need either one, copy and paste it from the sample slide. If you choose not to use a Sub-Heading, let us know when you hand in your presentation for clean-up and we’ll adjust where the bullets begin on your master page. Also, be sure to insert the presentation title onto the BULLETED LIST MASTER as follows: Choose View / Master / Slide Master from your menu. Select the text at the bottom of the slide and type in a short version of your presentation title. Click the SLIDE VIEW button in the lower left hand part of your screen to return to the slide show. (Small white rectangle) 30 Thrombus aspiration Standard PCI only 15

Secondary Endpoints: Angiography Results Secondary Endpoints: Angiography MBG post-PCI, % Thrombus aspiration Standard PCI only 1 2 3 10 17 70 5 20 67 p=0.83 Thrombus aspiration Standard PCI only 1 2 3 9 7 6 79 8 15 69 p=0.44 TIMI flow post-PCI, % This is the Bulleted List slide. To create this particular slide, click the NEW SLIDE button on your toolbar and choose the BULLETED LIST format. (Top row, second from left) The Sub-Heading and footnote will not appear when you insert a new slide. If you need either one, copy and paste it from the sample slide. If you choose not to use a Sub-Heading, let us know when you hand in your presentation for clean-up and we’ll adjust where the bullets begin on your master page. Also, be sure to insert the presentation title onto the BULLETED LIST MASTER as follows: Choose View / Master / Slide Master from your menu. Select the text at the bottom of the slide and type in a short version of your presentation title. Click the SLIDE VIEW button in the lower left hand part of your screen to return to the slide show. (Small white rectangle) 16

Secondary Endpoints: Enzymatic Infarct Size Results Secondary Endpoints: Enzymatic Infarct Size Thrombus aspiration Troponin T at 24 h, ng/l Standard PCI only p=0.24 4000 3000 2000 1000 Thrombus aspiration Troponin T at 48 h, ng/l Standard PCI only p=0.75 4000 3000 2000 1000 3150±2140 3031±2189 2995±2395 2588±1908 This is the Bulleted List slide. To create this particular slide, click the NEW SLIDE button on your toolbar and choose the BULLETED LIST format. (Top row, second from left) The Sub-Heading and footnote will not appear when you insert a new slide. If you need either one, copy and paste it from the sample slide. If you choose not to use a Sub-Heading, let us know when you hand in your presentation for clean-up and we’ll adjust where the bullets begin on your master page. Also, be sure to insert the presentation title onto the BULLETED LIST MASTER as follows: Choose View / Master / Slide Master from your menu. Select the text at the bottom of the slide and type in a short version of your presentation title. Click the SLIDE VIEW button in the lower left hand part of your screen to return to the slide show. (Small white rectangle) 17

Secondary Endpoints: Clinical Outcome Results Secondary Endpoints: Clinical Outcome Thrombus aspiration n = 70 Standard PCI n = 74 P Value All-cause death, n (%) 2 (3) 4 (5) 0.68 Cardiovascular death, n (%) 3 (4) 1.0 Reinfarction, n (%) - TVR, n (%) 0.24 TLR, n (%) Stent thrombosis, n (%) Stroke, n (%) 1 (1) This is the Bulleted List slide. To create this particular slide, click the NEW SLIDE button on your toolbar and choose the BULLETED LIST format. (Top row, second from left) The Sub-Heading and footnote will not appear when you insert a new slide. If you need either one, copy and paste it from the sample slide. If you choose not to use a Sub-Heading, let us know when you hand in your presentation for clean-up and we’ll adjust where the bullets begin on your master page. Also, be sure to insert the presentation title onto the BULLETED LIST MASTER as follows: Choose View / Master / Slide Master from your menu. Select the text at the bottom of the slide and type in a short version of your presentation title. Click the SLIDE VIEW button in the lower left hand part of your screen to return to the slide show. (Small white rectangle) 18

Conclusion In patients with subacute STEMI routine manual thrombus aspiration before PCI failed to show a significant reduction in the primary endpoint of MVO assessed by CMR, as compared to conventional PCI alone. The finding is supported by a lack of benefit in angiographic, enzymatic, and clinical secondary endpoints. This is the Bulleted List slide. To create this particular slide, click the NEW SLIDE button on your toolbar and choose the BULLETED LIST format. (Top row, second from left) The Sub-Heading and footnote will not appear when you insert a new slide. If you need either one, copy and paste it from the sample slide. If you choose not to use a Sub-Heading, let us know when you hand in your presentation for clean-up and we’ll adjust where the bullets begin on your master page. Also, be sure to insert the presentation title onto the BULLETED LIST MASTER as follows: Choose View / Master / Slide Master from your menu. Select the text at the bottom of the slide and type in a short version of your presentation title. Click the SLIDE VIEW button in the lower left hand part of your screen to return to the slide show. (Small white rectangle) 19